ClinConnect ClinConnect Logo
Search / Trial NCT03109444

Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Apr 6, 2017

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Hip Growth Chart

ClinConnect Summary

This clinical trial is studying hip dysplasia, a condition where a baby's hip joint doesn't develop correctly. Researchers want to gather information about how healthy hips look in newborns aged 32 to 46 weeks, using ultrasound technology. The goal is to create a growth chart that will help doctors better understand and treat hip dysplasia in infants.

To participate, babies born at CRMC, whether they are full-term or premature, can join the study. This includes newborns from the hospital's regular maternity ward or the neonatal intensive care unit (NICU). However, babies with certain conditions, like known genetic issues that affect the hips or immediate treatment needs for dislocated hips, will not be eligible. If your baby joins the study, they will undergo a simple ultrasound that will help gather important information for future treatments. This research aims to improve care for infants with hip dysplasia and is currently looking for participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • newborns born at CRMC (term newborns and pre-mature newborns over 32 weeks gestational age.
  • newborns in NICU
  • newborns on postpartum floor
  • single birth
  • multiple births
  • normal presentation
  • breach presentation
  • Exclusion Criteria:
  • known neuromuscular or genetic condition predisposing infant to hip dysplasia (i.e. Spina Bifida, Cerebral Palsy),
  • inability to follow up (i.e. doesn't live in surrounding area),
  • frankly dislocated hips that require immediate treatment,
  • any medical condition precluding safe hip ultrasound.

About University Of California, San Francisco

The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.

Locations

Fresno, California, United States

Patients applied

0 patients applied

Trial Officials

John Wiemann, MD

Principal Investigator

UCSF - Fresno

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials